Back to Search
LILLIAN CHAN, PHARMD
PHARMD
Pharmacist
NPI: 1497039176Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Proposed rectal dose constraints for patients undergoing definitive whole pelvic radiotherapy for clinically localized prostate cancer.
PMID 18342454·Int J Radiat Oncol Biol Phys·2008
6-review
LPA3 receptor mediates chemotaxis of immature murine dendritic cells to unsaturated lysophosphatidic acid (LPA).
PMID 17709403·J Leukoc Biol·2007
7-preclinical
Role of radiation therapy in the treatment of unfavorable risk prostate cancer.
PMID 17268397·Minerva Urol Nefrol·2006
6-review
Moving culture beyond ethnicity: examining dying in hospital through a cultural lens.
PMID 19678464·J Palliat Care·2009
6-review
Population differentiation of temperate amphibians in unpredictable environments.
PMID 19573030·Mol Ecol·2009
7-preclinical
Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function.
PMID 19440389·PLoS One·2009
8-other
Huge sphenoid sinus olfactory neuroblastoma: a case report.
PMID 19321412·Kaohsiung J Med Sci·2009
5-case
The protein phosphatase 2A functions in the spindle position checkpoint by regulating the checkpoint kinase Kin4.
PMID 19605686·Genes Dev·2009
8-other
China engages global health governance: processes and dilemmas.
PMID 19153928·Glob Public Health·2009
7-preclinical
Protocol evaluation of the total suspended solids and suspended sediment concentration methods: solid recovery efficiency and application for stormwater analysis.
PMID 18939603·Water Environ Res·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 275 SACRAMENTO ST
SAN FRANCISCO, CA 94111 - Phone
- (415) 362-5227
Quick Facts
- NPI
- 1497039176
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile